NASDAQ · ABCM
Healthcare · Biotechnology
$23.99
Up+$0.01 (+0.04%)
Updated Aug 16, 2026, 6:02 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
ABCM does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning ABCM.
ABCM research
Company profile and research snapshot.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 31, 2023 | RBC Capital | Sector Perform | — |
| Oct 9, 2023 | RBC Capital | Sector Perform | — |
| Aug 30, 2023 | SVB Leerink | Market Perform | — |
| Aug 22, 2023 | RBC Capital | Sector Perform | — |
| Jun 20, 2023 | RBC Capital | Sector Perform | — |
No generated briefing is available yet.
businesswire.com · Oct 21, 2025
CAMBRIDGE, England & LOS ANGELES--(BUSINESS WIRE)-- #Biotech--Molecular Instruments® and Abcam partner to announce plug-and-play HCR™ HiFi Encoder compatibility with Abcam's primaries.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ABCM.
No results
No recent SID articles mention ABCM.
